東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Prediction of high-responding peptid...

Boston University.

FindBook

Google Book

Amazon

博客來

Prediction of high-responding peptides in electrospray mass spectrometry.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Prediction of high-responding peptides in electrospray mass spectrometry./
作者:	Fusaro, Vincent A.
面頁冊數:	113 p.
附註:	Adviser: Jill P. Mesirov.
Contained By:	Dissertation Abstracts International70-01B.
標題:	Biology, Bioinformatics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3345652
ISBN:	9781109003642

Prediction of high-responding peptides in electrospray mass spectrometry.
Fusaro, Vincent A.

Prediction of high-responding peptides in electrospray mass spectrometry. - 113 p.

Adviser: Jill P. Mesirov.

Thesis (Ph.D.)--Boston University, 2009.

Protein biomarkers are derived from mass spectrometry (MS)-based proteomic data, integrative genomic studies using microarrays, and literature mining. This often results in many tens to hundreds of candidates whose presence and concentration must be verified in blood, the biofluid of choice, prior to developing a clinical assay. Historically, verification was performed using antibodies; however, the required immunoassay-grade reagents necessary for sensitive and specific detection in blood only exist for a tiny fraction of the proteome. Thus, alternative technologies are required to bridge the gap between discovery and clinical assay development.

ISBN: 9781109003642Subjects--Topical Terms:

1018415
Biology, Bioinformatics.

Prediction of high-responding peptides in electrospray mass spectrometry.
LDR:03337nam 2200301 a 45 001 861272
005 20100719
008 100719s2009 ||||||||||||||||| ||eng d
020 $a 9781109003642
035 $a (UMI)AAI3345652
035 $a AAI3345652
040 $a UMI $c UMI
100 1 $a Fusaro, Vincent A. $3 1028953
245 1 0 $a Prediction of high-responding peptides in electrospray mass spectrometry.
300 $a 113 p.
500 $a Adviser: Jill P. Mesirov.
500 $a Source: Dissertation Abstracts International, Volume: 70-01, Section: B, page: 0027.
502 $a Thesis (Ph.D.)--Boston University, 2009.
520 $a Protein biomarkers are derived from mass spectrometry (MS)-based proteomic data, integrative genomic studies using microarrays, and literature mining. This often results in many tens to hundreds of candidates whose presence and concentration must be verified in blood, the biofluid of choice, prior to developing a clinical assay. Historically, verification was performed using antibodies; however, the required immunoassay-grade reagents necessary for sensitive and specific detection in blood only exist for a tiny fraction of the proteome. Thus, alternative technologies are required to bridge the gap between discovery and clinical assay development.
520 $a Targeted hypothesis-driven mass spectrometry is increasingly being used to verify changes in protein response due to disease or therapy. These methods require selecting "signature" peptides as detectable and quantifiable surrogates for each protein. Peptides that produce the highest ion-current response are ideal choices as they are more sensitively detected. Unfortunately, selection of these peptides, particularly in the absence of experimental data, is a challenging problem and represents a significant resource constraint in targeted assay development by mass spectrometry.
520 $a This thesis describes the development of the Enhanced Signature Peptide (ESP) predictor, a computational method to predict high-responding peptides from a given protein. I used an MS-based analysis of yeast to define a training set and took advantage of the theoretical properties of the Random Forest (RF) algorithm, an ensemble of individual classification trees, to model peptide response. On average, the ESP predictor achieves a success rate of 89% at selecting one or more high-responding peptides per protein. More importantly, we applied the ESP predictor to select de novo signature peptides and show that it correctly selected 74% of experimentally validated signature peptides (2 peptides per protein on average). Furthermore, the ESP predictor is a robust model that, unlike existing computational methods, performs well across all common electrospray ionization (ESI)-MS experimental types. The ESP predictor fills a critical gap, enabling selection of optimal candidate signature peptides to detect and quantify any protein of interest in the absence of MS experimental data. We anticipate the use of the ESP predictor will greatly improve the efficiency of biomarker verification.
590 $a School code: 0017.
650 4 $a Biology, Bioinformatics. $3 1018415
650 4 $a Computer Science. $3 626642
690 $a 0715
690 $a 0984
710 2 $a Boston University. $3 1017454
773 0 $t Dissertation Abstracts International $g 70-01B.
790 $a 0017
790 1 0 $a Mesirov, Jill P., $e advisor
791 $a Ph.D.
792 $a 2009
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3345652